| Literature DB >> 34822469 |
Marta Monteiro1,2, Carla Sousa2, Filipe Coutinho1, Carolina Castro1, Filipa Fontinha1,2, Inês Guerreiro1, Pedro Pousão3, Elisabete Matos4,5, Patrícia Díaz-Rosales1,6, Aires Oliva-Teles1,2, Paula Enes1,2, Ana Couto1,2.
Abstract
Marine algae are recognised sources of bioactive compounds that have attracted great interest as nutritional supplements for aquaculture fish. Intensive rearing conditions often expose fish to husbandry-related stressors, rendering fish more susceptible to disease and reducing production yields. The present work evaluated the potential of two marine algae extracts (Fucus vesiculosus and Nannochloropsis gaditana) as nutritional supplements to mitigate stress effects in meagre (Argyrosomus regius) exposed to an acute handling stress (AS). A plant-based diet was used as a control, and three other diets were prepared, which were similar to the control diet but supplemented with 1% of each algal extract or a combination of the two extracts (0.5% each). The effects of supplemented diets on stress biomarkers, antioxidant enzyme activities, and immune response were analysed in fish exposed to AS after 4 weeks of feeding. Supplemented diets did not affect growth performance but the inclusion of F. vesiculosus promoted higher feed efficiency, as compared to the control group. Dietary algal extracts supplementation reduced plasma glucose levels, increased white blood cell counts, and reduced the expression of pro-inflammatory genes when compared with the control. N. gaditana supplementation led to a reduction in hepatic antioxidant enzyme activity and glutathione levels, while F. vesiculosus supplementation increased muscle glutathione reductase activity and reduced lipid peroxidation. These findings support the potential of algal extracts as nutraceuticals in aquafeeds to enhance the ability of fish to cope with husbandry-related stressful conditions and ultimately improve fish health and welfare.Entities:
Keywords: algal extracts; aquaculture fish; functional diet; immunomodulation; oxidative stress
Mesh:
Substances:
Year: 2021 PMID: 34822469 PMCID: PMC8617847 DOI: 10.3390/md19110598
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Growth performance, ingestion and feed efficiency of meagre (initial body weight (IBW)—28.8 g) fed the experimental diets for four weeks.
| Diets | Final Body Weight (g) | Weight Gain (%IBW) | Feed Intake | Feed Efficiency |
|---|---|---|---|---|
| N0F0 | 42.7 ± 1.17 | 48 ± 5 | 8.0 ± 0.7 | 0.6 ± 0.1 |
| N0F1 | 45.9 ± 3.22 | 59 ± 14 | 8.3 ± 1.1 | 0.7 ± 0.1 |
| N1F0 | 41.9± 3.39 | 40 ± 14 | 9.1 ± 1.2 | 0.5 ± 0.1 |
| N1F1 | 40.3 ± 2.15 | 45 ± 9 | 8.1 ± 1.0 | 0.6 ± 0.0 |
| Two-way ANOVA † | Final Body Weight | Feed Intake | Feed Intake | Feed Efficiency |
| N | ns | ns | ns | * |
| F | ns | ns | ns | * |
| N * F | ns | ns | ns | ns |
ABW—Average body weight = (initial body weight + final body weight)/2. FE—Feed efficiency = weight gain/dry feed intake. † Data are presented as mean ± SD (n = 3). Data were analysed by a 2-way ANOVA with Nannochloropsis (N) and Fucus (F) as factors; ns: non-significant; * p < 0.05.
Plasma biochemistry parameters for no-stress and acute-handling-stress meagre fed the experimental diets.
| Treatment | Diets | Glucose (mmol L−1) | Lactate (mmol L−1) | Cortisol (μg L−1) | |||
|---|---|---|---|---|---|---|---|
| No stress (NS) | N0F0 | 3.7 ± 0.9 | 3.9 ± 1.2 | 1.6 ± 0.0 | |||
| N0F1 | 3.3 ± 0.7 | 3.4 ± 1.3 | 1.0 ± 0.4 | ||||
| N1F0 | 3.0 ± 0.6 | 3.5 ± 0.8 | 0.9 ± 0.5 | ||||
| N1F1 | 3.0 ± 0.6 | 3.8 ± 0.9 | 1.4 ± 1.4 | ||||
| Acute handling stress (AS) | N0F0 | 5.1 ± 0.5 | 3.5 ± 0.9 | 6.2 ± 3.5 | |||
| N0F1 | 4.6 ± 0.9 | 2.7 ± 1.1 | 12.5 ± 7.2 | ||||
| N1F0 | 4.9 ± 0.8 | 2.6 ± 0.9 | 15.5± 21.8 | ||||
| N1F1 | 4.8 ± 0.7 | 2.9 ± 0.8 | 14.6 ± 4.8 | ||||
| Three-way ANOVA † | Mann–Whitney | ||||||
| Glucose | Lactate | Cortisol | |||||
| N | * | ns | ns | ||||
| F | * | ns | ns | ||||
| Stress | *** | *** | *** | ||||
| N * F | ns | * | - | ||||
| N * Stress | * | ns | - | ||||
| F * Stress | ns | ns | - | ||||
| N * F * Stress | ns | ns | - | ||||
| Glucose Interactions | No stress | Acute stress | N0 | N1 | F0 | F1 | |
| N0 vs. N1 | ** | ns | - | - | - | - | |
| AS vs. NS | - | - | *** | *** | - | - | |
| Lactate Interactions | |||||||
| F0 vs. F1 | - | - | * | ns | - | - | |
| N0 vs. N1 | - | - | - | - | * | ns | |
† Data are presented as mean ± SD (n = 9). Data were analysed by a 3-way ANOVA with N. gaditana (N), F. vesiculosus (F) and Stress as factors. When interaction between 2 factors was significant (p < 0.05), analysis of the main effects for each factor was conducted by one-way ANOVA. Cortisol was analysed using the non-parametric Mann–Whitney U test; ns: non-significant; * p < 0.05; ** p < 0.01; *** p < 0.001.
Hematological profile of no-stress and acute-handling-stress meagre fed the experimental diets.
| Treatment | Diets | RBC (106 mm−3) | WBC (104 mm−3) | Thrombocytes (104 mm−3) | Lymphocytes (104 mm−3) | Monocytes (104 mm−3) | Neutrophils (104 mm−3) | Hematocrit (%) | MCV |
|---|---|---|---|---|---|---|---|---|---|
| No stress (NS) | N0F0 | 1.5 ± 0.3 | 7.8 ± 0.9 | 115.0 ± 7.0 | 74.8 ± 6.4 | 7.7 ± 5.0 | 2.6 ± 3.3 | 22.1 ± 2.6 | 153.2 ± 18.2 |
| N0F1 | 1.4 ± 0.2 | 7.8 ± 1.0 | 118.2 ± 6.7 | 74.2 ± 6.0 | 5.9 ± 4.2 | 1.7 ± 1.9 | 21.1 ± 5.0 | 155.4 ± 64.2 | |
| N1F0 | 1.4 ± 0.3 | 7.2 ± 1.3 | 122.0 ± 5.1 | 73.7 ± 5.2 | 3.8 ± 2.2 | 0.6 ± 0.5 | 19.8 ± 2.7 | 144.8 ± 26 | |
| N1F1 | 1.4 ± 0.2 | 8.6 ± 1.4 | 115.1 ± 6.2 | 76.9 ± 4.8 | 5.8 ± 2.4 | 2.2 ± 2.7 | 19.9 ± 0.8 | 142.8 ± 18.0 | |
| Acute handling stress (AS) | N0F0 | 1.5 ± 0.3 | 7.0 ± 2.5 | 121.3 ± 8.6 | 66.8 ± 7.5 | 8.6 ± 4.4 | 3.3 ± 3.4 | 23.7 ± 2.5 | 161.2 ± 34.2 |
| N0F1 | 1.5 ± 0.1 | 7.9 ± 1.0 | 121.8 ± 5.0 | 67.8 ± 4.4 | 8.6 ± 4.6 | 1.9 ± 1.8 | 19.6 ± 2.4 | 131.4 ± 18.2 | |
| N1F0 | 1.6 ± 0.2 | 7.4 ± 1.1 | 120.8 ± 11.4 | 67.4 ± 8.1 | 9.8 ± 4.2 | 2.7 ± 1.6 | 21.2 ± 2.0 | 135.7 ± 20.2 | |
| N1F1 | 1.6 ± 0.2 | 8.2 ± 0.9 | 122.2 ± 8.2 | 67.4 ± 7.5 | 4.3 ± 3.0 | 6.0 ± 4.3 | 23.2 ± 2.8 | 144.3 ± 23.1 | |
| Three-way ANOVA † | RBC (106 mm−3) | WBC (104 mm−3) | Thrombocytes | Lymphocytes | Monocytes | Neutrophils | Hematocrit (%) | MCV | |
| N | ns | ns | ns | ns | ns | ns | ns | ns | |
| F | ns | * | ns | ns | ns | ns | ns | ns | |
| Stress | * | ns | * | *** | * | ** | ns | ns | |
| N * F | ns | ns | ns | ns | ns | ** | ns | ns | |
| N * Stress | ns | ns | ns | ns | ns | ns | * | ns | |
| F * Stress | ns | ns | ns | ns | ns | ns | ns | ns | |
| N * F * Stress | ns | ns | ns | ns | ns | ns | ns | ns | |
| Neutrophils Interactions | No stress | Acute stress | N0 | N1 | F0 | F1 | |||
| F0 vs. F1 | - | - | ns | * | - | - | |||
| N0 vs. N1 | - | - | - | - | ns | * | |||
| Hematocrit Interactions | |||||||||
| AS vs. NS | - | - | ns | * | - | - | |||
| N0 vs. N1 | * | ns | - | - | - | - | |||
RBC—Total red blood cells; WBC—white blood cells; MCV—mean corpuscular volume. When interaction between 2 factors was significant (p < 0.05), analysis of the main effects for each factor was conducted by one-way ANOVA. Cortisol was analysed using the non-parametric Mann–Whitney U test; ns: non-significant; * p < 0.05; ** p < 0.01; *** p < 0.001.
Figure 1Expression of immune-related genes in the head-kidney of meagre under no-stress (NS) and acute-handling-stress (AS) conditions, after four weeks of feeding with the experimental diets. (A) TNF-α, (B) IL-1β and (C) IL-10. Data are presented as mean ± SD (n = 9). Different letters indicate significant differences between dietary treatments ((A) p = 0.004; (B) p = 0.001; (C) p = 0.006). * indicate differences between NS and AS fish within each dietary treatment ((A) p = 0.035; (B) p = 0.002; (C) p = 0.001).
Figure 2Expression of HSP70 (A) and HSP90 (B) genes in the muscle of meagre under no-stress (NS) and acute-handling-stress (AS) conditions, after four weeks of feeding with the experimental diets. Data are presented as mean ± SD (n = 9). * indicate differences between NS and AS fish within the dietary treatment (p = 0.016).
Hepatic antioxidant enzymes activity in no-stress and acute-handling-stress meagre fed the experimental diets.
| Treatment | Diets | SOD | CAT | GPX | GR | G6PDH |
|---|---|---|---|---|---|---|
| No stress (NS) | N0F0 | 444.5 ± 52.1 | 318.5 ± 75.8 | 135.7 ± 24.2 | 13.3 ± 0.8 | 73.4 ± 18.8 |
| N0F1 | 462.3 ± 77.3 | 358.2 ± 57.9 | 156.1 ± 25.3 | 12.6 ± 1.3 | 87.5 ± 13.3 | |
| N1F0 | 334.9 ± 40.0 | 317.1 ± 54.2 | 136.5 ± 23.8 | 12.3 ± 1.5 | 75.3 ± 19.5 | |
| N1F1 | 395.2 ± 52.8 | 327.7 ± 53.8 | 138.3 ± 26.9 | 11.6 ± 1.4 | 73.1 ± 11.7 | |
| Acute handling stress (AS) | N0F0 | 622.1 ± 134.7 | 308.1 ± 46.2 | 626.9 ± 100.8 | 15.1 ± 0.6 | 98.3 ± 10.0 |
| N0F1 | 576.9 ± 149.2 | 300.2 ± 33.7 | 591.8 ± 89.1 | 13.6 ± 2.3 | 88.9 ± 20.7 | |
| N1F0 | 538.4 ± 125.2 | 287.4 ± 36.1 | 574.7 ± 56.1 | 13.6 ± 0.8 | 78.3 ± 13.3 | |
| N1F1 | 401.9 ± 53.0 | 321 ± 24.7 | 595.4 ± 56.1 | 13.6 ± 2.2 | 85.6 ± 15.6 | |
| Three-way ANOVA † | SOD | CAT | GPX | GR | G6PDH | |
| N | *** | ns | ns | * | * | |
| F | ns | ns | ns | ns | ns | |
| Stress | *** | ns | *** | *** | * | |
| N * F | ns | ns | ns | ns | ns | |
| N * Stress | ns | ns | ns | ns | ns | |
| F * Stress | * | ns | ns | ns | ns | |
| N * F * Stress | ns | ns | ns | ns | ns | |
SOD—Superoxide distumase (U mg protein−1); CAT—Catalase (U mg protein−1); GPX—Gluthatione Peroxidase; GR—Gluthatione Reductase (mU mg protein−1); G6PDH—Glucose-6-Phosphate Dehydrogenase (mU mg protein−1). † Data are presented as mean ± SD (n = 9). Data were analysed by a 3-way ANOVA with N. gaditana (N), F. vesiculosus (F) and Stress as factors. When interaction between 2 factors was p < 0.05, analysis of the main effects for each factor was conducted via a one-way ANOVA; ns: non-significant; * p < 0.05; *** p < 0.001.
Hepatic lipid peroxidation, glutathione (total, reduced and oxidised glutathione), and oxidative stress index of no-stress and acute-stress meagre fed the experimental diets.
| Treatment | Diets | tGSH | GSH | GSSG | OSI | LPO |
|---|---|---|---|---|---|---|
| No stress (NS) | N0F0 | 1924.5 ± 265.5 | 1819.7 ± 282.1 | 104.8 ± 58.4 | 11.2 ± 6.7 | 21.8 ± 6.4 |
| N0F1 | 2015 ± 309.5 | 1887 ± 314 | 86.7 ± 22.9 | 8.8 ± 3.1 | 24.1 ± 12.8 | |
| N1F0 | 2030.4 ± 92.3 | 1951.9 ± 123.3 | 78.5 ± 42.2 | 7.9 ± 4.6 | 20.3 ± 4.5 | |
| N1F1 | 1896.8 ± 270.3 | 1825.6 ± 271.7 | 71.2 ± 32.6 | 7.6 ± 3.6 | 22.6 ± 9 | |
| Acute stress (AS) | N0F0 | 1817.4 ± 117.3 | 1747.2 ± 123.9 | 70.2 ± 38.2 | 7.8 ± 4.1 | 25.2 ± 3.6 |
| N0F1 | 1856.6 ± 209.4 | 1772.4 ± 240.6 | 71.8 ± 21.3 | 7.6 ± 2.6 | 29.3 ± 7.2 | |
| N1F0 | 1624.1 ± 136.4 | 1599.4 ± 291 | 91.6 ± 46.3 | 11.1 ± 5.5 | 27.8 ± 8.9 | |
| N1F1 | 1573.7 ± 110.3 | 1531.4 ± 109.4 | 44.2 ± 21 | 5.4 ± 2.7 | 21.7 ± 5.1 | |
| Three-way ANOVA † | tGSH | GSH | GSSG | OSI | LPO | |
| N | * | ns | ns | ns | ns | |
| F | ns | ns | ns | ns | ns | |
| Stress | *** | ** | ns | ns | ns | |
| N * F | ns | ns | ns | ns | ns | |
| N * Stress | * | ns | ns | ns | ns | |
| F * Stress | ns | ns | ns | ns | ns | |
| N * F *Stress | ns | ns | ns | ns | ns | |
| tGSH Interactions | No stress | Acute stress | N0 | N1 | ||
| N0 vs. N1 | ns | ** | - | - | ||
| AS vs. NS | - | - | ns | *** | ||
LPO—lipid peroxidation (nmol malondialdehyde. g tissue−1); tGSH—total glutathione; GSH—reduced glutathione (nmol/g tissue); GSSG—oxidised glutathione (nmol/ g tissue); OSI—oxidative stress index. † Data are presented as mean ± SD (n = 9). Data were analysed by a 3-way ANOVA with N. gaditana (N), F. vesiculosus (F) and Stress as factors. When interaction between 2 factors was p < 0.05, analysis of the main effects for each factor was conducted via a one-way ANOVA; ns: non-significant; * p < 0.05; ** p < 0.01; *** p < 0.001.
Muscle antioxidant enzymes activity in no-stress and acute-handling-stress meagre fed the experimental diets.
| Treatment | Diets | SOD | CAT | GPX | GR | G6PDH | |
|---|---|---|---|---|---|---|---|
| No stress (NS) | N0F0 | 101.8 ± 19.7 | 0.9 ± 0.2 | 18.9 ± 1.8 | 1.4 ± 0.5 | 0.5 ± 0.1 | |
| N0F1 | 106.8 ± 32.8 | 0.9 ± 0.2 | 23.4 ± 3.8 | 1.9 ± 0.3 | 0.6 ± 0.2 | ||
| N1F0 | 114.3 ± 13.1 | 1.0 ± 0.2 | 20.8 ± 4.4 | 1.6 ± 0.3 | 0.4 ± 0.1 | ||
| N1F1 | 88.1 ± 24.8 | 1.1 ± 0.3 | 22.0 ± 3.5 | 1.9 ± 0.5 | 0.5 ± 0.2 | ||
| Acute stress (S) | N0F0 | 101.8 ± 31.7 | 1.3 ± 0.4 | 18.1 ± 3.8 | 1.5 ± 0.3 | 0.5 ± 0.2 | |
| N0F1 | 116.5 ± 40.3 | 1.3 ± 0.6 | 20.8 ± 4.7 | 1.8 ± 0.4 | 0.6 ± 0.2 | ||
| N1F0 | 107.5 ± 18.0 | 1.5 ± 0.4 | 16.0 ± 6.7 | 1.6 ± 0.4 | 0.5 ± 0.1 | ||
| N1F1 | 103.1 ± 24.4 | 1.3 ± 0.4 | 15.1 ± 3.8 | 1.3 ± 0.2 | 0.5 ± 0.1 | ||
| Three-way ANOVA † | SOD | CAT | GPX | GR | G6PDH | ||
| N | ns | * | ns | ns | * | ||
| F | ns | ns | ns | * | ns | ||
| Stress | ns | * | ** | ns | ns | ||
| N * F | ns | ns | ns | * | ns | ||
| N * Stress | ns | ns | ns | ns | ns | ||
| F * Stress | ns | ns | ns | * | ns | ||
| N * F * Stress | ns | ns | ns | ns | ns | ||
| GR Interactions | No stress | Acute stress | N0 | N1 | F0 | F1 | |
| F0 vs. F1 | * | ns | * | ns | - | - | |
| NS vs. AS | - | - | - | - | ns | * | |
| N0 vs. N1 | - | - | - | - | ns | * | |
SOD—Superoxide distumase (U mg protein−1); CAT—Catalase (U mg protein−1); GPX—Gluthatione Peroxidase; GR—Gluthatione Reductase (mU mg protein−1); G6PDH—Glucose-6-Phosphate Dehydrogenase (mU mg protein−1). † Data are presented as mean ± SD (n = 9). Data were analysed by a 3-way ANOVA with N. gaditana (N), F. vesiculosus (F) and Stress as factors. When interaction between 2 factors was p < 0.05, analysis of the main effects for each factor was conducted via a one-way ANOVA; ns: non-significant; * p < 0.05; ** p < 0.01.
Muscle lipid peroxidation, glutathione (total, reduced and oxidised glutathione), and oxidative stress index of no-stress and acute-handling-stress meagre fed the experimental diets.
| Treatment | Diets | tGSH | GSH | GSSG | OSI | LPO |
|---|---|---|---|---|---|---|
| No stress (NS) | N0F0 | 179.3 ± 22.5 | 174.9± 22.0 | 5.1 ± 0.7 | 5.6 ± 0.9 | 1.7 ± 1.1 |
| N0F1 | 189.4 ± 26.1 | 184.5 ± 26.3 | 4.6 ± 1.2 | 5.2 ± 1.6 | 0.6 ± 0.4 | |
| N1F0 | 165.1 ± 22.1 | 160.4 ± 23.5 | 4.7 ± 1.6 | 6.1 ± 2.9 | 0.9 ± 0.6 | |
| N1F1 | 172.0 ± 35.1 | 164.8 ± 34.8 | 7.0 ± 5.3 | 6.3 ± 2.1 | 0.6 ± 0.4 | |
| Acute stress (S) | N0F0 | 194.9 ± 24.2 | 186.3± 24.3 | 8.6 ± 4.8 | 8.9 ± 5.1 | 2.3 ± 1.1 |
| N0F1 | 188.9± 32.1 | 179.8± 31.5 | 9.1 ± 3.9 | 9.9 ± 4.5 | 1.5 ± 0.4 | |
| N1F0 | 200.7 ± 23.5 | 190.3 ± 22.6 | 9.8 ± 4.5 | 10.3 ± 4.2 | 1.7 ± 0.5 | |
| N1F1 | 184.6 ± 23.3 | 173.1 ± 25.5 | 11.5 ± 3.5 | 13.0 ± 5.1 | 2.2 ± 1.7 | |
| Three-way ANOVA † | tGSH | GSH | GSSG | OSI | LPO | |
| N | ns | ns | ns | ns | ns | |
| F | ns | ns | ns | ns | * | |
| Stress | * | ns | *** | *** | *** | |
| N * F | ns | ns | ns | ns | ns | |
| N * Stress | ns | ns | ns | ns | ns | |
| F * Stress | ns | ns | ns | ns | ns | |
| N * F * Stress | ns | ns | ns | ns | ns | |
LPO—lipid peroxidation (nmol malondialdehyde. g tissue-1); tGSH—total glutathione; GSH—reduced glutathione (nmol/g tissue); GSSG—oxidised glutathione (nmol/g tissue); OSI—oxidative stress index. † Data are presented as mean ± SD (n = 9). Data were analysed by a 3-way ANOVA with N. gaditana (N), F. vesiculosus (F) and Stress as factors; ns: non-significant; * p < 0.05; *** p < 0.001.
Composition and proximate analysis of the experimental diets.
| Diets | ||||
|---|---|---|---|---|
| N0F0 | N1F0 | N0F1 | N1F1 | |
|
| ||||
| Fish meal 1 | 25.0 | 25.0 | 25.0 | 25.0 |
| Wheat gluten 2 | 5.0 | 5.0 | 5.0 | 5.0 |
| Corn gluten 3 | 15.0 | 15.0 | 15.0 | 15.0 |
| Soybean meal 4 | 32.4 | 32.4 | 32.4 | 32.4 |
| Wheat meal 5 | 0.9 | 0.9 | 0.9 | 0.9 |
| Cellulose | 1.5 | 0.5 | 0.5 | 0.5 |
| Ammonium phosphate | 1.3 | 1.3 | 1.3 | 1.3 |
| Cod liver oil | 5.2 | 5.2 | 5.2 | 5.2 |
| Soy bean oil | 5.0 | 5.0 | 5.0 | 5.0 |
| Rapeseed oil | 5.0 | 5.0 | 5.0 | 5.0 |
| Taurine 6 | 0.2 | 0.2 | 0.2 | 0.2 |
| Vitamin mix 7 | 1.0 | 1.0 | 1.0 | 1.0 |
| Mineral mix 8 | 1.0 | 1.0 | 1.0 | 1.0 |
| Binder 9 | 1.0 | 1.0 | 1.0 | 1.0 |
| Choline chloride (50%) | 0.5 | 0.5 | 0.5 | 0.5 |
| 0.0 | 1.0 | 0.0 | 0.5 | |
| 0.0 | 0.0 | 1.0 | 0.5 | |
|
| ||||
| Dry matter (%) | 92.4 | 93.6 | 92.7 | 93.7 |
| Crude protein (%) | 48.1 | 48.4 | 49.6 | 49.7 |
| Crude fat (%) | 15.2 | 16.0 | 15.7 | 16.0 |
| Gross Energy (kJ g−1 % DM) | 22.2 | 22.3 | 22.4 | 22.4 |
| Ash (%) | 11.4 | 11.3 | 11.6 | 11.4 |
CP—Crude Protein. TL—Total lipid. 1 Sorgal, S.A. Ovar, Portugal (CP: 72.4%; TL: 17.0%). 2 Sorgal, S.A. Ovar, Portugal (CP: 84.6%; TL: 1.0%).3 Sorgal, S.A. Ovar, Portugal (CP: 69.9%; TL: 3.3%) 4 Sorgal, S.A. Ovar, Portugal (CP: 54.2%; TL: 1.8%). 5 Sorgal, S.A. Ovar, Portugal (CP: 13.8%; TL: 1.1%). 6 Feed-grade, Sorgal, S.A. Ovar, Portugal. 7 Vitamins (mg kg−1 diet): retinol, 18,000 (IU kg−1 diet); calciferol, 2000 (IU kg−1 diet); alpha tocopherol, 35; menadion sodium bis., 10; thiamin, 15; riboflavin, 25; calcium pantothenate, 50; nicotinic acid, 200; pyridoxine, 5; folic acid, 10; cyanocobalamin, 0.02; biotin, 1.5; ascorbyl monophosphate, 50; inositol, 400. 8 Minerals (mg kg−1 diet): cobalt sulphate, 1.91; copper sulphate, 19.6; iron sulphate, 200; sodium fluoride, 2.21; potassium iodide, 0.78; magnesium oxide, 830; manganese oxide, 26; sodium selenite, 0.66; zinc oxide, 37.5; dicalcium phosphate, 8.02 (g kg−1 diet); potassium chloride, 1.15 (g kg−1 diet); sodium chloride, 0.4 (g kg−1 diet). 9 Aquacube. Agil, UK. 10 Total phenolic content (TPC): 0.72 ± 0.08 mg galic acid (GA) g−1 dry weight; 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) radical scavenging activity: 24.97 ± 2.01 μmol 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) g−1 dry weight; 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity: 5.78 ± 0.48 μmol Trolox g−1 dry weight. (Determined in [26].). 11 Total phenolic content (TPC): 7.93 ± 0.34 mg GA g−1 dry weight; ABTS radical scavenging activity: 99.37 ± 11.27 μmol Trolox g−1 dry weight; DPPH radical scavenging activity: 81.54 ± 6.71 μmol Trolox g−1 dry weight. (Determined in [26].).
Primer sequences used for transcript amplification by RT-PCR.
| Gene | Sequence | Efficiency | Amplicon (bp) | Reference |
|---|---|---|---|---|
| EF-1α | F: TACGGTTCCGATACCGCCG | 2.0 | 189 | [ |
| R: AACATGCTTGAGGGCAGTGACAA | ||||
| IL-1β | F: GATTGCCTGGATTTTCCACTGTCTCCA | 2.3 | 103 | [ |
| R: GTGGCTCTGGGCATCAAGGG | ||||
| IL-10 | F: ACTCCTCGGTCTCTCCTCGTATCCGC | 2.1 | 187 | [ |
| R: CTGTGTCGAGATCATCGTTGGCTTCATAAAAGTC | ||||
| TNF-α | F: CACAAGAGCGGCCATTCATTTACAAGGAG | 1.8 | 173 | [ |
| R: GGAAAGACGCTTGGCTGTAGATGG | ||||
| HSP70 | F: ATCACAGTTCCGGCGTATTT | 1.9 | 197 | Present study |
| R: ATGGACACGTCAAAGGTGCC | ||||
| HSP90 | F: ATCGTGGAGACTCTCAGGCA | 1.9 | 146 | Present study |
| R: CTGTAGATGCGGTTGGAGTG |